Stock Scorecard



Stock Summary for Exicure Inc (XCUR) - $11.44 as of 5/10/2025 1:56:51 PM EST

Total Score

10 out of 30

Safety Score

16 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for XCUR

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for XCUR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for XCUR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for XCUR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for XCUR (16 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 0
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for XCUR

Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - CN Energy Group ( NASDAQ:CNEY ) , Bolt Projects Holdings ( NASDAQ:BSLK ) 12/4/2024 10:11:00 AM
How Is The Market Feeling About Exicure? - Exicure ( NASDAQ:XCUR ) 11/26/2024 3:15:00 PM
Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Akoustis Technologies ( NASDAQ:AKTS ) , Allot ( NASDAQ:ALLT ) 11/25/2024 10:27:00 AM
Why Nike Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Nike ( NYSE:NKE ) 9/20/2024 10:00:00 AM
Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket - BurgerFi International ( NASDAQ:BFI ) , Allarity Therapeutics ( NASDAQ:ALLR ) 9/19/2024 9:26:00 AM
Exicure Stock Is Soaring After The Bell: What's Driving The Action? - Exicure ( NASDAQ:XCUR ) 9/18/2024 8:51:00 PM
Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying - Exicure ( NASDAQ:XCUR ) 9/17/2024 1:01:00 PM
What's Going On With Exicure Shares Monday? - Exicure ( NASDAQ:XCUR ) 9/16/2024 5:43:00 PM
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket - Exicure ( NASDAQ:XCUR ) 9/16/2024 10:07:00 AM
Coda Octopus, RF Industries And 3 Stocks To Watch Heading Into Monday - Coda Octopus Group ( NASDAQ:CODA ) 9/16/2024 6:29:00 AM

Financial Details for XCUR

Company Overview

Ticker XCUR
Company Name Exicure Inc
Country USA
Description Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2024
Next Earnings Date 6/4/2025

Stock Price History

Last Day Price 11.44
Price 4 Years Ago 30.32
Last Day Price Updated 5/10/2025 1:56:51 PM EST
Last Day Volume 5,987
Average Daily Volume 24,747
52-Week High 36.00
52-Week Low 1.44
Last Price to 52 Week Low 694.44%

Valuation Measures

Trailing PE N/A
Industry PE 30.10
Sector PE 47.92
5-Year Average PE -3.43
Free Cash Flow Ratio 5.78
Industry Free Cash Flow Ratio 18.49
Sector Free Cash Flow Ratio 30.82
Current Ratio Most Recent Quarter 4.45
Total Cash Per Share 1.98
Book Value Per Share Most Recent Quarter 1.12
Price to Book Ratio 10.62
Industry Price to Book Ratio 35.42
Sector Price to Book Ratio 27.83
Price to Sales Ratio Twelve Trailing Months 144.55
Industry Price to Sales Ratio Twelve Trailing Months 89.39
Sector Price to Sales Ratio Twelve Trailing Months 25.47
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 6,317,800
Market Capitalization 72,275,632
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 42.65%
Reported EPS 12 Trailing Months -4.75
Reported EPS Past Year 0.00
Reported EPS Prior Year -2.44
Net Income Twelve Trailing Months -9,701,000
Net Income Past Year -9,701,000
Net Income Prior Year -16,914,000
Quarterly Revenue Growth YOY 928.00%
5-Year Revenue Growth -17.34%
Operating Margin Twelve Trailing Months -990.00%

Balance Sheet

Total Cash Most Recent Quarter 12,508,000
Total Cash Past Year 12,508,000
Total Cash Prior Year 816,000
Net Cash Position Most Recent Quarter 12,508,000
Net Cash Position Past Year 12,508,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 6,873,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 6,772,000
Total Stockholder Equity Prior Year 3,031,000
Total Stockholder Equity Most Recent Quarter 6,772,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -2,910,000
Free Cash Flow Per Share Twelve Trailing Months -0.46
Free Cash Flow Past Year -2,910,000
Free Cash Flow Prior Year -10,357,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.36
MACD Signal -0.36
20-Day Bollinger Lower Band 7.21
20-Day Bollinger Middle Band 11.58
20-Day Bollinger Upper Band 15.94
Beta 3.87
RSI 51.37
50-Day SMA 6.20
150-Day SMA 0.00
200-Day SMA 28.14

System

Modified 5/10/2025 1:57:37 PM EST